290 related articles for article (PubMed ID: 36561615)
1. Role of ion channels in the mechanism of proteinuria (Review).
Liu J; Li X; Xu N; Han H; Li X
Exp Ther Med; 2023 Jan; 25(1):27. PubMed ID: 36561615
[TBL] [Abstract][Full Text] [Related]
2. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
Szabó T; Ambrus L; Zákány N; Balla G; Bíró T
Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740
[TBL] [Abstract][Full Text] [Related]
3. Fetal Renal Stem Cell Transplant in Nephrotic and Nonnephrotic Glomerulonephritis with Stage 2-4 Chronic Kidney Disease: Potential Effect on Proteinuria and Glomerular Filtration Rate.
Tuganbekova S; Gaipov A; Turebekov Z; Saparbayev S; Shaimardanova G; Popova N; Taubaldiyeva Z; Serebrennikova D; Trimova R
Exp Clin Transplant; 2015 Nov; 13 Suppl 3():156-9. PubMed ID: 26640940
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of renal NaCl retention in proteinuric disease.
Svenningsen P; Friis UG; Versland JB; Buhl KB; Møller Frederiksen B; Andersen H; Zachar RM; Bistrup C; Skøtt O; Jørgensen JS; Andersen RF; Jensen BL
Acta Physiol (Oxf); 2013 Mar; 207(3):536-45. PubMed ID: 23216619
[TBL] [Abstract][Full Text] [Related]
5. Proteinuria: detection and role in native renal disease progression.
Gorriz JL; Martinez-Castelao A
Transplant Rev (Orlando); 2012 Jan; 26(1):3-13. PubMed ID: 22137726
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of cellular synchronization in the vascular wall. Mechanisms of vasomotion.
Matchkov VV
Dan Med Bull; 2010 Oct; 57(10):B4191. PubMed ID: 21040688
[TBL] [Abstract][Full Text] [Related]
7. Nephrotic range proteinuria as a strong risk factor for rapid renal function decline during pre-dialysis phase in type 2 diabetic patients with severely impaired renal function.
Kitai Y; Doi Y; Osaki K; Sugioka S; Koshikawa M; Sugawara A
Clin Exp Nephrol; 2015 Dec; 19(6):1037-43. PubMed ID: 25680889
[TBL] [Abstract][Full Text] [Related]
8. Effects of receptor-mediated endocytosis and tubular protein composition on volume retention in experimental glomerulonephritis.
Kastner C; Pohl M; Sendeski M; Stange G; Wagner CA; Jensen B; Patzak A; Bachmann S; Theilig F
Am J Physiol Renal Physiol; 2009 Apr; 296(4):F902-11. PubMed ID: 19193726
[TBL] [Abstract][Full Text] [Related]
9. Ion channels as a therapeutic target for renal fibrosis.
Yan P; Ke B; Fang X
Front Physiol; 2022; 13():1019028. PubMed ID: 36277193
[TBL] [Abstract][Full Text] [Related]
10. Ion channels and transporters in microglial function in physiology and brain diseases.
Luo L; Song S; Ezenwukwa CC; Jalali S; Sun B; Sun D
Neurochem Int; 2021 Jan; 142():104925. PubMed ID: 33248207
[TBL] [Abstract][Full Text] [Related]
11. A native prokaryotic voltage-dependent calcium channel with a novel selectivity filter sequence.
Shimomura T; Yonekawa Y; Nagura H; Tateyama M; Fujiyoshi Y; Irie K
Elife; 2020 Feb; 9():. PubMed ID: 32093827
[TBL] [Abstract][Full Text] [Related]
12. ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome.
Ruggenenti P; Mosconi L; Vendramin G; Moriggi M; Remuzzi A; Sangalli F; Remuzzi G
Am J Kidney Dis; 2000 Mar; 35(3):381-91. PubMed ID: 10692263
[TBL] [Abstract][Full Text] [Related]
13. Proteinuric diseases with sodium retention: Is plasmin the link?
Svenningsen P; Skøtt O; Jensen BL
Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):117-24. PubMed ID: 21466573
[TBL] [Abstract][Full Text] [Related]
14. [Instructions and implementations for percutaneous renal biopsy. Guidelines for the therapy of glomerular nephropaties].
Cagnoli L;
G Ital Nefrol; 2003; 20 Suppl 24():S3-47. PubMed ID: 14666502
[TBL] [Abstract][Full Text] [Related]
15. Functional significance of channels and transporters expressed in the inner ear and kidney.
Lang F; Vallon V; Knipper M; Wangemann P
Am J Physiol Cell Physiol; 2007 Oct; 293(4):C1187-208. PubMed ID: 17670895
[TBL] [Abstract][Full Text] [Related]
16. Activation of ion transport pathways by changes in cell volume.
Sarkadi B; Parker JC
Biochim Biophys Acta; 1991 Dec; 1071(4):407-27. PubMed ID: 1721542
[TBL] [Abstract][Full Text] [Related]
17. Potassium channel openers as potential therapeutic weapons in ion channel disease.
Lawson K
Kidney Int; 2000 Mar; 57(3):838-45. PubMed ID: 10720937
[TBL] [Abstract][Full Text] [Related]
18. A case report of immunoglobulin M nephropathy manifesting as crescentic glomerulonephritis and nephrotic syndrome in an adult.
Park KS; Kang EW; Kie JH
BMC Nephrol; 2019 Aug; 20(1):335. PubMed ID: 31455257
[TBL] [Abstract][Full Text] [Related]
19. Effects of cyclosporin A on glomerular barrier function in the nephrotic syndrome.
Zietse R; Wenting GJ; Kramer P; Schalekamp MA; Weimar W
Clin Sci (Lond); 1992 Jun; 82(6):641-50. PubMed ID: 1320544
[TBL] [Abstract][Full Text] [Related]
20. Characterization of proteinuria in primary glomerulonephritides: urinary polymers of albumin.
Bazzi C; Petrini C; Rizza V; Arrigo G; Beltrame A; D'Amico G
Am J Kidney Dis; 1997 Sep; 30(3):404-12. PubMed ID: 9292570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
